BioSpace News Archive

Policy

BioSpace’s Global Biopharma Roundup: March 28

BioSpace takes a quick look at some of the news coming from biotech and pharma companies from across Europe and Asia.

March 27, 2019
·
7 min read
·
Alex Keown
Business

New Study Finds Remarkable Benefits of SeroVital Consumption

New data presented at ENDO 2019 Conference in New Orleans on March 24, 2019

March 27, 2019
·
2 min read
The Nomination Committee´s Proposal for New Board of Directors to the Annual General Meeting 2019

Medivir AB announces the Nomination Committee’s proposal for a new Board of Directors to the Annual General Meeting 2019.

March 27, 2019
·
2 min read
Ready-to-use most cost-efficient and effective way to counter hospital-acquired infections: Clorox® Professional Products Canada

When it comes to fighting hospital-acquired infections, the efficiency and efficacy of ready-to-use disinfectants is unparalleled.

March 27, 2019
·
2 min read
Business

Centene and WellCare to Combine to Create a Premier Healthcare Enterprise Focused on Government-Sponsored Healthcare Programs

Centene Corporation and WellCare Health Plans, Inc. announced that Centene will acquire WellCare in a cash and stock transaction for $305.39 per share based on Centene’s closing stock price on March 26, 2019 for a total enterprise value of $17.3 billion pursuant to the terms of a definitive merger agreement.

March 27, 2019
·
29 min read
Business

CannabisBPO, CannaTech, and iCAN: Israel Cannabis Expands Partnership

CannabisBPO to Provide Contact Center Support for iCAN Cannabis Ecosystem

March 27, 2019
·
2 min read
Biotech Bay

Gilead to Present New Data From Multiple Liver Disease Research and Development Programs at The International Liver Congress™ 2019

More Than 35 Abstracts Across NASH, PSC and Viral Hepatitis Reflect Ongoing Commitment to Advancing Liver Disease Research and Patient Care

March 27, 2019
·
15 min read
Policy

First Subjects Enrolled in Clinical Study to Evaluate Safety and Efficacy of OMNI™ Surgical System for Multiple Micro-Invasive Glaucoma Surgery Procedures

Sight Sciences announced enrollment has begun in the Gemini clinical study, a Sight Sciences-sponsored, prospective, multi-center study to evaluate the safety and efficacy of the OMNI™ Surgical System in performing two sequential Micro-Invasive Glaucoma Surgery procedures – transluminal viscoelastic delivery and trabeculotomy.

March 27, 2019
·
4 min read
Drug Development

BioLineRx Announces Successful Engraftment Data From Phase 3 GENESIS Trial for BL-8040 in Multiple Myeloma Patients

Results presented as oral presentation at 45th Annual Meeting of European Society for Blood and Marrow Transplantation

March 27, 2019
·
7 min read
BioForest

Health care leaders back Xealth with Series A funding to digitally enable patient care

McKesson Ventures, Novartis, Philips, ResMed join Threshold Ventures, the Froedtert & MCW Health Network, Providence Ventures, UPMC to accelerate Xealth’s digital health prescribing platform

March 27, 2019
·
4 min read